ACTIVE

TELEMEDICINE TECHNOLOGIES BELGIUM

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result5,3 k €+101,8 %over 1 year
Gross margin319,5 k €+292,5 %over 1 year
Equity-935,6 k €+0,6 %over 1 year

Identity

Source · BCE/KBO

TELEMEDICINE TECHNOLOGIES BELGIUM is a Public limited company incorporated in 2021. Its main activity is: Other software publishing. Its registered office is in Liège.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0767.854.077
Incorporation
05/05/2021
Legal form
Public limited company
Registered office
Boulevard de Patience et Beaujonc 3
4000 Liège · WallonieSee on map
Contributed capital
300 000,00 €
Latest accounts
31/12/2025
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin319,5 k €81,4 k €185,5 k €173,3 k €87,7 k €
EBITDA18,6 k €-257,8 k €-165,6 k €-264,7 k €-314 k €
Operating result12,9 k €-294,2 k €-230,7 k €-328,8 k €-345,6 k €
Net result5,3 k €-303,8 k €-242,3 k €-343,7 k €-351,1 k €
Balance sheet
Equity-935,6 k €-940,9 k €-637,1 k €-394,8 k €-151,1 k €
Total assets378,5 k €432,7 k €201,3 k €288,8 k €556,3 k €
Cash5,5 k €71,9 k €40,4 k €73,2 k €287 k €
Debts1,3 M €1,4 M €810,2 k €663,1 k €685,2 k €
Other
Workforce–6,4 ETP7,9 ETP8,9 ETP7,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 2 ended

Active mandates

Hugues Gourbat

Personne chargée de la gestion journalière · since 19 juin 2024

Active
Thierry Lepoutre

Director · since 10 mai 2021

Active

Ended mandates

H.P.G. FINANCIAL GROUP SARL

Director · since 05 mai 2021 · until 19 juin 2024

Represented by Hugues GOURBAT

Ended
H.P.G. FINANCIAL GROUP SARL

Director · since 05 mai 2021

Represented by Hugues GOURBAT

Ended

Other companies at this address

Boulevard de Patience et Beaujonc 3 4000 Liège
CompanyCBE no.
Abscint● Active
0749.828.410
AMPACIMON● Active
0827.990.317
Amyl Therapeutics● Active
0758.775.372
BECARV● Bankrupt
0840.777.885
BE.SPINE● Active
1013.110.857
CEFALY Technology● Active
0870.578.661
DERMAX● Active
0667.730.677
DIANOSIC● Active
1034.558.646
DW Cefaly Holding● Active
0725.837.241
EARTH ALIVE CLEAN TECHNOLOGIES BELGIUM● Active
1023.778.481
EXO Biologics● Active
0732.982.379
ExoXpert● Active
1003.807.666
Hirundo Biosciences● Active
0681.855.065
HolyFox Invest● Active
1010.693.181
Hyloris● Active
0669.738.676
Hyloris Developments● Active
0542.737.368
Hyloris Pharmaceuticals● Active
0674.494.151
Hyloris Therapeutics● Active
1025.029.385
LEGIAPARK● Active
0728.589.170
MAN & SCIENCE● Active
0837.403.770

Full financial information

Source · NBB
20252024202320222021
Type of accountMicro modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202205/05/2021
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months8 months
Filing date22/06/202617/07/202517/07/202420/07/202328/06/2022
General meeting17/06/202616/06/202519/06/202421/06/202330/05/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202517/06/202622/06/2026FrenchPDF
Abridged model31/12/202416/06/202517/07/2025FrenchPDF
Abridged model31/12/202319/06/202417/07/2024FrenchPDF
Abridged model31/12/202221/06/202320/07/2023FrenchPDF
Abridged model31/12/202130/05/202228/06/2022FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 2 ended

Active mandates

Hugues Gourbat

Personne chargée de la gestion journalière · since 19 juin 2024

Active
Thierry Lepoutre

Director · since 10 mai 2021

Active

Ended mandates

H.P.G. FINANCIAL GROUP SARL

Director · since 05 mai 2021 · until 19 juin 2024

Represented by Hugues GOURBAT

Ended
H.P.G. FINANCIAL GROUP SARL

Director · since 05 mai 2021

Represented by Hugues GOURBAT

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office07/08/2023
    SIEGE SOCIAL - ADRESSE AUTRE QUE SIEGE SOCIAL
    PDF
  • Mandates02/08/2021
    DEMISSIONS, NOMINATIONS
    PDF
  • Other07/05/2021
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20255,3 k €↑
  2. 2024
    Annual accounts 2024-303,8 k €↓
  3. 2023
    Annual accounts 2023-242,3 k €↑
  4. 2022
    Annual accounts 2022-343,7 k €↑
  5. 2021
    Annual accounts 2021-351,1 k €
  6. 05/05/2021
    IncorporationPublic limited company